3150-AK91 202504 Unified Agenda of Federal Regulatory and Deregulatory Actions 3150 Nuclear Regulatory Commission NRC Reporting Nuclear Medicine Injection Extravasations as Medical Events [NRC-2022-0218]

This rulemaking would amend the NRC’s regulations to require reporting of certain nuclear medicine injection extravasations as medical events and to require medical licensees to develop, implement, and maintain written procedures for evaluating and reporting extravasations. This proposed rule would affect medical licensees that administer intravenous radiopharmaceuticals for diagnostic and therapeutic purposes. The NRC engaged the public during the pre-rulemaking stage through meetings with stakeholders; the publication of preliminary proposed rule language; and public meetings.

]]> Substantive, Nonsignificant Previously Published in The Unified Agenda Proposed Rule Stage Undetermined No Other 10 CFR 35 44 U.S.C. 2201 44 U.S.C. 5841 No Preliminary Proposed Rule Language 04/19/2023 88 FR 24130 Comment Period End 07/18/2023 Comment Period Extended 07/18/2023 88 FR 45824 Comment Period Extension End 09/01/2023 NPRM 07/00/2025 Final Rule 09/00/2026 The proposed rule package (SECY-24-0067, ADAMS Accession No. ML24016A294) was submitted to the Commission on August 13, 2024. No No None No No No Irene Wu 3150 Nuclear Regulatory Commission NRC 301 415-1951 irene.wu@nrc.gov Office of Nuclear Material Safety and Safeguards, Washington DC 20555-0001